Regencell Bioscience Holdings (Regencell Bioscience Holdings) Total Liabilities : $0.63 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Total Liabilities?

Regencell Bioscience Holdings's Total Liabilities for the quarter that ended in Jun. 2023 was $0.63 Mil.

Regencell Bioscience Holdings's quarterly Total Liabilities declined from Jun. 2022 ($0.94 Mil) to Dec. 2022 ($0.87 Mil) and declined from Dec. 2022 ($0.87 Mil) to Jun. 2023 ($0.63 Mil).

Regencell Bioscience Holdings's annual Total Liabilities declined from Jun. 2021 ($4.34 Mil) to Jun. 2022 ($0.94 Mil) and declined from Jun. 2022 ($0.94 Mil) to Jun. 2023 ($0.63 Mil).

Regencell Bioscience Holdings Total Liabilities Historical Data

The historical data trend for Regencell Bioscience Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Total Liabilities Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

2.08

3.17

4.34

0.94

0.63

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Liabilities	Get a 7-Day Free Trial				4.34	1.36	0.94	0.87	0.63

Regencell Bioscience Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Regencell Bioscience Holdings's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.607	+	(0.025	+	2.0816681711722E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.63

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	12.622	-	11.989
	=	0.63

Regencell Bioscience Holdings's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.607	+	(0.025	+	2.0816681711722E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.63

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	12.622	-	11.989
	=	0.63

Regencell Bioscience Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.